nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP3A5—prostate cancer	0.115	0.358	CbGaD
Pentamidine—CYP4A11—Estrone—prostate cancer	0.0978	0.228	CbGbCtD
Pentamidine—CYP2C19—prostate cancer	0.0785	0.244	CbGaD
Pentamidine—CYP1A1—prostate cancer	0.0782	0.243	CbGaD
Pentamidine—CYP3A4—prostate cancer	0.0499	0.155	CbGaD
Pentamidine—CYP1A1—Flutamide—prostate cancer	0.0246	0.0574	CbGbCtD
Pentamidine—CYP1A1—Estrone—prostate cancer	0.0178	0.0415	CbGbCtD
Pentamidine—CYP2C8—Nilutamide—prostate cancer	0.0172	0.04	CbGbCtD
Pentamidine—CYP3A5—Flutamide—prostate cancer	0.0148	0.0345	CbGbCtD
Pentamidine—CYP2C19—Bicalutamide—prostate cancer	0.0144	0.0336	CbGbCtD
Pentamidine—CYP2C19—Nilutamide—prostate cancer	0.0144	0.0336	CbGbCtD
Pentamidine—CYP2C8—Abiraterone—prostate cancer	0.0142	0.0332	CbGbCtD
Pentamidine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0132	0.0309	CbGbCtD
Pentamidine—CYP2C19—Flutamide—prostate cancer	0.0119	0.0278	CbGbCtD
Pentamidine—CYP1A2—Flutamide—prostate cancer	0.011	0.0257	CbGbCtD
Pentamidine—CYP2D6—Bicalutamide—prostate cancer	0.0109	0.0255	CbGbCtD
Pentamidine—CYP3A5—Cabazitaxel—prostate cancer	0.0109	0.0255	CbGbCtD
Pentamidine—CYP3A5—Estrone—prostate cancer	0.0107	0.0249	CbGbCtD
Pentamidine—CYP2C8—Cabazitaxel—prostate cancer	0.0105	0.0245	CbGbCtD
Pentamidine—CYP1A1—Estradiol—prostate cancer	0.0102	0.0239	CbGbCtD
Pentamidine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00916	0.0214	CbGbCtD
Pentamidine—CYP2D6—Abiraterone—prostate cancer	0.00907	0.0211	CbGbCtD
Pentamidine—CYP1A2—Estrone—prostate cancer	0.00796	0.0186	CbGbCtD
Pentamidine—CYP3A4—Bicalutamide—prostate cancer	0.00696	0.0162	CbGbCtD
Pentamidine—CYP3A4—Estramustine—prostate cancer	0.00647	0.0151	CbGbCtD
Pentamidine—CYP3A5—Estradiol—prostate cancer	0.00614	0.0143	CbGbCtD
Pentamidine—CYP2C8—Estradiol—prostate cancer	0.0059	0.0138	CbGbCtD
Pentamidine—CYP3A4—Abiraterone—prostate cancer	0.00577	0.0134	CbGbCtD
Pentamidine—CYP3A4—Flutamide—prostate cancer	0.00577	0.0134	CbGbCtD
Pentamidine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00521	0.0121	CbGbCtD
Pentamidine—CYP2C19—Estradiol—prostate cancer	0.00495	0.0115	CbGbCtD
Pentamidine—CYP1A2—Estradiol—prostate cancer	0.00457	0.0107	CbGbCtD
Pentamidine—CYP3A4—Cabazitaxel—prostate cancer	0.00427	0.00995	CbGbCtD
Pentamidine—CYP2C19—Prednisone—prostate cancer	0.00426	0.00993	CbGbCtD
Pentamidine—CYP3A4—Estrone—prostate cancer	0.00417	0.00972	CbGbCtD
Pentamidine—CYP3A5—Etoposide—prostate cancer	0.00401	0.00935	CbGbCtD
Pentamidine—CYP2C8—Etoposide—prostate cancer	0.00386	0.00899	CbGbCtD
Pentamidine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00372	0.00866	CbGbCtD
Pentamidine—CYP3A5—Docetaxel—prostate cancer	0.00367	0.00855	CbGbCtD
Pentamidine—CYP1A2—Etoposide—prostate cancer	0.00298	0.00696	CbGbCtD
Pentamidine—AOC1—prostate gland—prostate cancer	0.00293	0.128	CbGeAlD
Pentamidine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00273	0.00636	CbGbCtD
Pentamidine—CYP3A4—Mitoxantrone—prostate cancer	0.00248	0.00578	CbGbCtD
Pentamidine—CYP3A4—Estradiol—prostate cancer	0.00239	0.00558	CbGbCtD
Pentamidine—CYP3A4—Prednisone—prostate cancer	0.00206	0.0048	CbGbCtD
Pentamidine—AOC1—renal system—prostate cancer	0.002	0.0875	CbGeAlD
Pentamidine—AOC1—urethra—prostate cancer	0.00196	0.086	CbGeAlD
Pentamidine—CYP2C19—urine—prostate cancer	0.00191	0.0836	CbGeAlD
Pentamidine—CYP2D6—Doxorubicin—prostate cancer	0.00168	0.00391	CbGbCtD
Pentamidine—CYP4A11—renal system—prostate cancer	0.00166	0.0727	CbGeAlD
Pentamidine—CYP3A4—Etoposide—prostate cancer	0.00156	0.00365	CbGbCtD
Pentamidine—CYP1A2—urine—prostate cancer	0.00156	0.0683	CbGeAlD
Pentamidine—AOC1—bone marrow—prostate cancer	0.00151	0.0662	CbGeAlD
Pentamidine—CYP3A4—Docetaxel—prostate cancer	0.00143	0.00334	CbGbCtD
Pentamidine—AOC1—testis—prostate cancer	0.00129	0.0566	CbGeAlD
Pentamidine—CYP3A4—urine—prostate cancer	0.00113	0.0494	CbGeAlD
Pentamidine—CYP2D6—urine—prostate cancer	0.00111	0.0487	CbGeAlD
Pentamidine—CYP3A4—Doxorubicin—prostate cancer	0.00107	0.00249	CbGbCtD
Pentamidine—AOC1—lymph node—prostate cancer	0.000937	0.041	CbGeAlD
Pentamidine—S100B—lymph node—prostate cancer	0.000817	0.0357	CbGeAlD
Pentamidine—Ospemifene—ESR1—prostate cancer	0.000657	0.432	CrCbGaD
Pentamidine—CYP3A5—prostate gland—prostate cancer	0.00054	0.0237	CbGeAlD
Pentamidine—Ospemifene—CYP2C19—prostate cancer	0.000527	0.347	CrCbGaD
Pentamidine—CYP2C8—renal system—prostate cancer	0.000408	0.0179	CbGeAlD
Pentamidine—CYP1A1—epithelium—prostate cancer	0.000406	0.0178	CbGeAlD
Pentamidine—CYP1A2—renal system—prostate cancer	0.000382	0.0167	CbGeAlD
Pentamidine—CYP1A1—renal system—prostate cancer	0.000377	0.0165	CbGeAlD
Pentamidine—CYP1A1—urethra—prostate cancer	0.00037	0.0162	CbGeAlD
Pentamidine—CYP3A5—renal system—prostate cancer	0.000368	0.0161	CbGeAlD
Pentamidine—Ospemifene—CYP3A4—prostate cancer	0.000335	0.221	CrCbGaD
Pentamidine—CYP3A4—renal system—prostate cancer	0.000276	0.0121	CbGeAlD
Pentamidine—CYP2D6—renal system—prostate cancer	0.000272	0.0119	CbGeAlD
Pentamidine—CYP2C8—testis—prostate cancer	0.000264	0.0115	CbGeAlD
Pentamidine—CYP1A1—lymph node—prostate cancer	0.000177	0.00772	CbGeAlD
Pentamidine—CYP2D6—testis—prostate cancer	0.000176	0.0077	CbGeAlD
Pentamidine—Dermatitis—Estradiol—prostate cancer	3.32e-05	0.000263	CcSEcCtD
Pentamidine—Anaemia—Prednisone—prostate cancer	3.31e-05	0.000263	CcSEcCtD
Pentamidine—Confusional state—Capecitabine—prostate cancer	3.31e-05	0.000263	CcSEcCtD
Pentamidine—Tachycardia—Docetaxel—prostate cancer	3.31e-05	0.000263	CcSEcCtD
Pentamidine—Headache—Estradiol—prostate cancer	3.3e-05	0.000262	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.29e-05	0.000261	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—prostate cancer	3.28e-05	0.00026	CcSEcCtD
Pentamidine—Angioedema—Prednisone—prostate cancer	3.28e-05	0.00026	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—prostate cancer	3.26e-05	0.000259	CcSEcCtD
Pentamidine—Infection—Capecitabine—prostate cancer	3.26e-05	0.000259	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—prostate cancer	3.25e-05	0.000258	CcSEcCtD
Pentamidine—Urticaria—Etoposide—prostate cancer	3.24e-05	0.000257	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—prostate cancer	3.24e-05	0.000257	CcSEcCtD
Pentamidine—Anorexia—Docetaxel—prostate cancer	3.23e-05	0.000256	CcSEcCtD
Pentamidine—Shock—Capecitabine—prostate cancer	3.23e-05	0.000256	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—prostate cancer	3.23e-05	0.000256	CcSEcCtD
Pentamidine—Abdominal pain—Etoposide—prostate cancer	3.23e-05	0.000256	CcSEcCtD
Pentamidine—Body temperature increased—Etoposide—prostate cancer	3.23e-05	0.000256	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—prostate cancer	3.23e-05	0.000256	CcSEcCtD
Pentamidine—Vertigo—Prednisone—prostate cancer	3.22e-05	0.000255	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—prostate cancer	3.22e-05	0.000255	CcSEcCtD
Pentamidine—Thrombocytopenia—Capecitabine—prostate cancer	3.22e-05	0.000255	CcSEcCtD
Pentamidine—Syncope—Prednisone—prostate cancer	3.21e-05	0.000255	CcSEcCtD
Pentamidine—Tachycardia—Capecitabine—prostate cancer	3.21e-05	0.000254	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—prostate cancer	3.2e-05	0.000254	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—prostate cancer	3.2e-05	0.000254	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—prostate cancer	3.17e-05	0.000252	CcSEcCtD
Pentamidine—Hypotension—Docetaxel—prostate cancer	3.17e-05	0.000251	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—prostate cancer	3.17e-05	0.000251	CcSEcCtD
Pentamidine—Loss of consciousness—Prednisone—prostate cancer	3.15e-05	0.00025	CcSEcCtD
Pentamidine—Anorexia—Capecitabine—prostate cancer	3.13e-05	0.000248	CcSEcCtD
Pentamidine—Nausea—Estradiol—prostate cancer	3.13e-05	0.000248	CcSEcCtD
Pentamidine—Vomiting—Mitoxantrone—prostate cancer	3.12e-05	0.000247	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—prostate cancer	3.11e-05	0.000247	CcSEcCtD
Pentamidine—Convulsion—Prednisone—prostate cancer	3.11e-05	0.000246	CcSEcCtD
Pentamidine—Hypertension—Prednisone—prostate cancer	3.1e-05	0.000245	CcSEcCtD
Pentamidine—Rash—Mitoxantrone—prostate cancer	3.09e-05	0.000245	CcSEcCtD
Pentamidine—Dermatitis—Mitoxantrone—prostate cancer	3.09e-05	0.000245	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.09e-05	0.000245	CcSEcCtD
Pentamidine—Headache—Mitoxantrone—prostate cancer	3.07e-05	0.000244	CcSEcCtD
Pentamidine—Hypotension—Capecitabine—prostate cancer	3.07e-05	0.000243	CcSEcCtD
Pentamidine—Insomnia—Docetaxel—prostate cancer	3.07e-05	0.000243	CcSEcCtD
Pentamidine—Arthralgia—Prednisone—prostate cancer	3.05e-05	0.000242	CcSEcCtD
Pentamidine—Myalgia—Prednisone—prostate cancer	3.05e-05	0.000242	CcSEcCtD
Pentamidine—Paraesthesia—Docetaxel—prostate cancer	3.05e-05	0.000242	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—prostate cancer	3.05e-05	0.000242	CcSEcCtD
Pentamidine—Anxiety—Prednisone—prostate cancer	3.04e-05	0.000241	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—prostate cancer	3.03e-05	0.000241	CcSEcCtD
Pentamidine—Dyspnoea—Docetaxel—prostate cancer	3.02e-05	0.00024	CcSEcCtD
Pentamidine—Somnolence—Docetaxel—prostate cancer	3.02e-05	0.000239	CcSEcCtD
Pentamidine—Discomfort—Prednisone—prostate cancer	3.02e-05	0.000239	CcSEcCtD
Pentamidine—Hypersensitivity—Etoposide—prostate cancer	3.01e-05	0.000239	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.99e-05	0.000237	CcSEcCtD
Pentamidine—Flushing—Epirubicin—prostate cancer	2.99e-05	0.000237	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—prostate cancer	2.99e-05	0.000237	CcSEcCtD
Pentamidine—Dyspepsia—Docetaxel—prostate cancer	2.99e-05	0.000237	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—prostate cancer	2.98e-05	0.000236	CcSEcCtD
Pentamidine—Insomnia—Capecitabine—prostate cancer	2.97e-05	0.000236	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—prostate cancer	2.97e-05	0.000235	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—prostate cancer	2.96e-05	0.000235	CcSEcCtD
Pentamidine—Paraesthesia—Capecitabine—prostate cancer	2.95e-05	0.000234	CcSEcCtD
Pentamidine—Decreased appetite—Docetaxel—prostate cancer	2.95e-05	0.000234	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—prostate cancer	2.94e-05	0.000233	CcSEcCtD
Pentamidine—Asthenia—Etoposide—prostate cancer	2.93e-05	0.000232	CcSEcCtD
Pentamidine—Dyspnoea—Capecitabine—prostate cancer	2.93e-05	0.000232	CcSEcCtD
Pentamidine—Anaphylactic shock—Prednisone—prostate cancer	2.93e-05	0.000232	CcSEcCtD
Pentamidine—Fatigue—Docetaxel—prostate cancer	2.92e-05	0.000232	CcSEcCtD
Pentamidine—Nausea—Mitoxantrone—prostate cancer	2.92e-05	0.000231	CcSEcCtD
Pentamidine—Infection—Prednisone—prostate cancer	2.91e-05	0.000231	CcSEcCtD
Pentamidine—Pain—Docetaxel—prostate cancer	2.9e-05	0.00023	CcSEcCtD
Pentamidine—Constipation—Docetaxel—prostate cancer	2.9e-05	0.00023	CcSEcCtD
Pentamidine—Dyspepsia—Capecitabine—prostate cancer	2.89e-05	0.000229	CcSEcCtD
Pentamidine—Chills—Epirubicin—prostate cancer	2.89e-05	0.000229	CcSEcCtD
Pentamidine—Pruritus—Etoposide—prostate cancer	2.89e-05	0.000229	CcSEcCtD
Pentamidine—Shock—Prednisone—prostate cancer	2.88e-05	0.000228	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—prostate cancer	2.88e-05	0.000228	CcSEcCtD
Pentamidine—Tachycardia—Prednisone—prostate cancer	2.86e-05	0.000226	CcSEcCtD
Pentamidine—Decreased appetite—Capecitabine—prostate cancer	2.86e-05	0.000226	CcSEcCtD
Pentamidine—Fatigue—Capecitabine—prostate cancer	2.83e-05	0.000225	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—prostate cancer	2.82e-05	0.000223	CcSEcCtD
Pentamidine—Pain—Capecitabine—prostate cancer	2.81e-05	0.000223	CcSEcCtD
Pentamidine—Constipation—Capecitabine—prostate cancer	2.81e-05	0.000223	CcSEcCtD
Pentamidine—Erythema—Epirubicin—prostate cancer	2.8e-05	0.000222	CcSEcCtD
Pentamidine—Feeling abnormal—Docetaxel—prostate cancer	2.8e-05	0.000222	CcSEcCtD
Pentamidine—Diarrhoea—Etoposide—prostate cancer	2.79e-05	0.000222	CcSEcCtD
Pentamidine—Anorexia—Prednisone—prostate cancer	2.79e-05	0.000221	CcSEcCtD
Pentamidine—Gastrointestinal pain—Docetaxel—prostate cancer	2.77e-05	0.00022	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—prostate cancer	2.77e-05	0.000219	CcSEcCtD
Pentamidine—Tension—Epirubicin—prostate cancer	2.75e-05	0.000218	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—prostate cancer	2.75e-05	0.000218	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—prostate cancer	2.72e-05	0.000216	CcSEcCtD
Pentamidine—Feeling abnormal—Capecitabine—prostate cancer	2.71e-05	0.000215	CcSEcCtD
Pentamidine—Dizziness—Etoposide—prostate cancer	2.7e-05	0.000214	CcSEcCtD
Pentamidine—Gastrointestinal pain—Capecitabine—prostate cancer	2.69e-05	0.000213	CcSEcCtD
Pentamidine—Body temperature increased—Docetaxel—prostate cancer	2.68e-05	0.000213	CcSEcCtD
Pentamidine—Abdominal pain—Docetaxel—prostate cancer	2.68e-05	0.000213	CcSEcCtD
Pentamidine—Chills—Doxorubicin—prostate cancer	2.67e-05	0.000212	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.67e-05	0.000211	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—prostate cancer	2.66e-05	0.000211	CcSEcCtD
Pentamidine—Insomnia—Prednisone—prostate cancer	2.65e-05	0.00021	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—prostate cancer	2.64e-05	0.00021	CcSEcCtD
Pentamidine—Paraesthesia—Prednisone—prostate cancer	2.63e-05	0.000208	CcSEcCtD
Pentamidine—Urticaria—Capecitabine—prostate cancer	2.61e-05	0.000207	CcSEcCtD
Pentamidine—Abdominal pain—Capecitabine—prostate cancer	2.6e-05	0.000206	CcSEcCtD
Pentamidine—Body temperature increased—Capecitabine—prostate cancer	2.6e-05	0.000206	CcSEcCtD
Pentamidine—Vomiting—Etoposide—prostate cancer	2.6e-05	0.000206	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—prostate cancer	2.59e-05	0.000206	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—prostate cancer	2.59e-05	0.000206	CcSEcCtD
Pentamidine—Dyspepsia—Prednisone—prostate cancer	2.58e-05	0.000204	CcSEcCtD
Pentamidine—Rash—Etoposide—prostate cancer	2.57e-05	0.000204	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—prostate cancer	2.57e-05	0.000204	CcSEcCtD
Pentamidine—Headache—Etoposide—prostate cancer	2.56e-05	0.000203	CcSEcCtD
Pentamidine—Tension—Doxorubicin—prostate cancer	2.55e-05	0.000202	CcSEcCtD
Pentamidine—Decreased appetite—Prednisone—prostate cancer	2.54e-05	0.000202	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—prostate cancer	2.54e-05	0.000202	CcSEcCtD
Pentamidine—Fatigue—Prednisone—prostate cancer	2.52e-05	0.0002	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—prostate cancer	2.52e-05	0.0002	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—prostate cancer	2.52e-05	0.0002	CcSEcCtD
Pentamidine—Syncope—Epirubicin—prostate cancer	2.51e-05	0.000199	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—prostate cancer	2.51e-05	0.000199	CcSEcCtD
Pentamidine—Constipation—Prednisone—prostate cancer	2.5e-05	0.000198	CcSEcCtD
Pentamidine—Hypersensitivity—Docetaxel—prostate cancer	2.5e-05	0.000198	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—prostate cancer	2.48e-05	0.000197	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—prostate cancer	2.46e-05	0.000195	CcSEcCtD
Pentamidine—Cough—Epirubicin—prostate cancer	2.45e-05	0.000194	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—prostate cancer	2.44e-05	0.000194	CcSEcCtD
Pentamidine—Asthenia—Docetaxel—prostate cancer	2.43e-05	0.000193	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—prostate cancer	2.43e-05	0.000193	CcSEcCtD
Pentamidine—Nausea—Etoposide—prostate cancer	2.42e-05	0.000192	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—prostate cancer	2.42e-05	0.000192	CcSEcCtD
Pentamidine—Hypersensitivity—Capecitabine—prostate cancer	2.42e-05	0.000192	CcSEcCtD
Pentamidine—Feeling abnormal—Prednisone—prostate cancer	2.41e-05	0.000191	CcSEcCtD
Pentamidine—Pruritus—Docetaxel—prostate cancer	2.4e-05	0.00019	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—prostate cancer	2.4e-05	0.00019	CcSEcCtD
Pentamidine—Gastrointestinal pain—Prednisone—prostate cancer	2.39e-05	0.00019	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—prostate cancer	2.39e-05	0.000189	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—prostate cancer	2.39e-05	0.000189	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—prostate cancer	2.39e-05	0.000189	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—prostate cancer	2.38e-05	0.000189	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—prostate cancer	2.36e-05	0.000187	CcSEcCtD
Pentamidine—Asthenia—Capecitabine—prostate cancer	2.36e-05	0.000187	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—prostate cancer	2.33e-05	0.000185	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—prostate cancer	2.33e-05	0.000185	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—prostate cancer	2.33e-05	0.000185	CcSEcCtD
Pentamidine—Urticaria—Prednisone—prostate cancer	2.32e-05	0.000184	CcSEcCtD
Pentamidine—Pruritus—Capecitabine—prostate cancer	2.32e-05	0.000184	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—prostate cancer	2.32e-05	0.000184	CcSEcCtD
Pentamidine—Diarrhoea—Docetaxel—prostate cancer	2.32e-05	0.000184	CcSEcCtD
Pentamidine—Abdominal pain—Prednisone—prostate cancer	2.31e-05	0.000183	CcSEcCtD
Pentamidine—Body temperature increased—Prednisone—prostate cancer	2.31e-05	0.000183	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—prostate cancer	2.31e-05	0.000183	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—prostate cancer	2.29e-05	0.000182	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—prostate cancer	2.29e-05	0.000181	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—prostate cancer	2.28e-05	0.000181	CcSEcCtD
Pentamidine—Infection—Epirubicin—prostate cancer	2.27e-05	0.00018	CcSEcCtD
Pentamidine—Cough—Doxorubicin—prostate cancer	2.26e-05	0.00018	CcSEcCtD
Pentamidine—Shock—Epirubicin—prostate cancer	2.25e-05	0.000179	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—prostate cancer	2.25e-05	0.000178	CcSEcCtD
Pentamidine—Diarrhoea—Capecitabine—prostate cancer	2.25e-05	0.000178	CcSEcCtD
Pentamidine—Dizziness—Docetaxel—prostate cancer	2.24e-05	0.000178	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—prostate cancer	2.24e-05	0.000178	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—prostate cancer	2.24e-05	0.000178	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—prostate cancer	2.23e-05	0.000177	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—prostate cancer	2.21e-05	0.000175	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—prostate cancer	2.21e-05	0.000175	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—prostate cancer	2.21e-05	0.000175	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—prostate cancer	2.2e-05	0.000175	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—prostate cancer	2.18e-05	0.000173	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—prostate cancer	2.18e-05	0.000173	CcSEcCtD
Pentamidine—Dizziness—Capecitabine—prostate cancer	2.17e-05	0.000172	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—prostate cancer	2.16e-05	0.000171	CcSEcCtD
Pentamidine—Vomiting—Docetaxel—prostate cancer	2.16e-05	0.000171	CcSEcCtD
Pentamidine—Hypersensitivity—Prednisone—prostate cancer	2.16e-05	0.000171	CcSEcCtD
Pentamidine—Rash—Docetaxel—prostate cancer	2.14e-05	0.00017	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—prostate cancer	2.14e-05	0.00017	CcSEcCtD
Pentamidine—Dermatitis—Docetaxel—prostate cancer	2.14e-05	0.00017	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—prostate cancer	2.13e-05	0.000169	CcSEcCtD
Pentamidine—Headache—Docetaxel—prostate cancer	2.13e-05	0.000169	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—prostate cancer	2.12e-05	0.000168	CcSEcCtD
Pentamidine—Infection—Doxorubicin—prostate cancer	2.1e-05	0.000167	CcSEcCtD
Pentamidine—Asthenia—Prednisone—prostate cancer	2.1e-05	0.000167	CcSEcCtD
Pentamidine—Vomiting—Capecitabine—prostate cancer	2.09e-05	0.000166	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.08e-05	0.000165	CcSEcCtD
Pentamidine—Shock—Doxorubicin—prostate cancer	2.08e-05	0.000165	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—prostate cancer	2.07e-05	0.000164	CcSEcCtD
Pentamidine—Rash—Capecitabine—prostate cancer	2.07e-05	0.000164	CcSEcCtD
Pentamidine—Pruritus—Prednisone—prostate cancer	2.07e-05	0.000164	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—prostate cancer	2.07e-05	0.000164	CcSEcCtD
Pentamidine—Dermatitis—Capecitabine—prostate cancer	2.07e-05	0.000164	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—prostate cancer	2.07e-05	0.000164	CcSEcCtD
Pentamidine—Headache—Capecitabine—prostate cancer	2.06e-05	0.000163	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—prostate cancer	2.05e-05	0.000163	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—prostate cancer	2.04e-05	0.000162	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—prostate cancer	2.03e-05	0.000161	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—prostate cancer	2.02e-05	0.00016	CcSEcCtD
Pentamidine—Nausea—Docetaxel—prostate cancer	2.02e-05	0.00016	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—prostate cancer	2.01e-05	0.00016	CcSEcCtD
Pentamidine—Diarrhoea—Prednisone—prostate cancer	2e-05	0.000159	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—prostate cancer	1.99e-05	0.000158	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—prostate cancer	1.98e-05	0.000157	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—prostate cancer	1.97e-05	0.000156	CcSEcCtD
Pentamidine—Constipation—Epirubicin—prostate cancer	1.96e-05	0.000155	CcSEcCtD
Pentamidine—Pain—Epirubicin—prostate cancer	1.96e-05	0.000155	CcSEcCtD
Pentamidine—Nausea—Capecitabine—prostate cancer	1.95e-05	0.000155	CcSEcCtD
Pentamidine—Dizziness—Prednisone—prostate cancer	1.93e-05	0.000153	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.93e-05	0.000153	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—prostate cancer	1.92e-05	0.000152	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—prostate cancer	1.9e-05	0.000151	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—prostate cancer	1.89e-05	0.00015	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—prostate cancer	1.89e-05	0.00015	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—prostate cancer	1.88e-05	0.000149	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—prostate cancer	1.87e-05	0.000148	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—prostate cancer	1.86e-05	0.000148	CcSEcCtD
Pentamidine—Vomiting—Prednisone—prostate cancer	1.86e-05	0.000148	CcSEcCtD
Pentamidine—Rash—Prednisone—prostate cancer	1.84e-05	0.000146	CcSEcCtD
Pentamidine—Dermatitis—Prednisone—prostate cancer	1.84e-05	0.000146	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—prostate cancer	1.84e-05	0.000146	CcSEcCtD
Pentamidine—Headache—Prednisone—prostate cancer	1.83e-05	0.000145	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—prostate cancer	1.83e-05	0.000145	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—prostate cancer	1.82e-05	0.000144	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—prostate cancer	1.81e-05	0.000144	CcSEcCtD
Pentamidine—Pain—Doxorubicin—prostate cancer	1.81e-05	0.000144	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—prostate cancer	1.81e-05	0.000143	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—prostate cancer	1.81e-05	0.000143	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—prostate cancer	1.74e-05	0.000138	CcSEcCtD
Pentamidine—Nausea—Prednisone—prostate cancer	1.74e-05	0.000138	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.73e-05	0.000137	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—prostate cancer	1.69e-05	0.000134	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—prostate cancer	1.68e-05	0.000133	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—prostate cancer	1.67e-05	0.000133	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—prostate cancer	1.67e-05	0.000133	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—prostate cancer	1.64e-05	0.00013	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—prostate cancer	1.62e-05	0.000128	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—prostate cancer	1.57e-05	0.000124	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—prostate cancer	1.56e-05	0.000124	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—prostate cancer	1.52e-05	0.00012	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—prostate cancer	1.51e-05	0.00012	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—prostate cancer	1.5e-05	0.000119	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—prostate cancer	1.45e-05	0.000115	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—prostate cancer	1.45e-05	0.000115	CcSEcCtD
Pentamidine—Rash—Epirubicin—prostate cancer	1.44e-05	0.000114	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—prostate cancer	1.44e-05	0.000114	CcSEcCtD
Pentamidine—Headache—Epirubicin—prostate cancer	1.43e-05	0.000114	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—prostate cancer	1.4e-05	0.000111	CcSEcCtD
Pentamidine—Nausea—Epirubicin—prostate cancer	1.36e-05	0.000108	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—prostate cancer	1.35e-05	0.000107	CcSEcCtD
Pentamidine—Rash—Doxorubicin—prostate cancer	1.33e-05	0.000106	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—prostate cancer	1.33e-05	0.000106	CcSEcCtD
Pentamidine—Headache—Doxorubicin—prostate cancer	1.33e-05	0.000105	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—prostate cancer	1.26e-05	9.98e-05	CcSEcCtD
Pentamidine—CYP2C8—Metabolism—NCOA1—prostate cancer	2.08e-06	2.1e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—COMT—prostate cancer	2.08e-06	2.1e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—prostate cancer	2.07e-06	2.09e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOA3—prostate cancer	2.06e-06	2.08e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2E1—prostate cancer	2.05e-06	2.07e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP19A1—prostate cancer	2.05e-06	2.07e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—prostate cancer	2.04e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA4—prostate cancer	2.04e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.04e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMS—prostate cancer	2.03e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ITPR1—prostate cancer	2.03e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NQO1—prostate cancer	2.03e-06	2.05e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NCOA2—prostate cancer	2.03e-06	2.05e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.02e-06	2.04e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—prostate cancer	2.01e-06	2.03e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2e-06	2.02e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TH—prostate cancer	2e-06	2.02e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.99e-06	2.01e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA2—prostate cancer	1.98e-06	2.01e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP3A4—prostate cancer	1.98e-06	2e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—RXRA—prostate cancer	1.98e-06	2e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—LPL—prostate cancer	1.97e-06	2e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.97e-06	1.99e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HPGDS—prostate cancer	1.96e-06	1.98e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.96e-06	1.98e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCG5—prostate cancer	1.96e-06	1.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2C19—prostate cancer	1.95e-06	1.97e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.94e-06	1.97e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.93e-06	1.95e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.92e-06	1.94e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMS—prostate cancer	1.92e-06	1.94e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA1—prostate cancer	1.91e-06	1.94e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1A1—prostate cancer	1.91e-06	1.93e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—COMT—prostate cancer	1.9e-06	1.93e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTT1—prostate cancer	1.9e-06	1.92e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ACHE—prostate cancer	1.9e-06	1.92e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—prostate cancer	1.9e-06	1.92e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—prostate cancer	1.9e-06	1.92e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NAT2—prostate cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTO1—prostate cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ERCC2—prostate cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GGT1—prostate cancer	1.88e-06	1.9e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2A6—prostate cancer	1.88e-06	1.9e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.87e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NQO1—prostate cancer	1.87e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ITPR1—prostate cancer	1.87e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—LPL—prostate cancer	1.86e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NCOA1—prostate cancer	1.86e-06	1.88e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TH—prostate cancer	1.84e-06	1.86e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.83e-06	1.85e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKR1C3—prostate cancer	1.83e-06	1.85e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.83e-06	1.85e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.82e-06	1.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PRKACB—prostate cancer	1.82e-06	1.84e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLCB2—prostate cancer	1.81e-06	1.83e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LRP2—prostate cancer	1.81e-06	1.83e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.81e-06	1.83e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP17A1—prostate cancer	1.8e-06	1.82e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.79e-06	1.81e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ERCC2—prostate cancer	1.79e-06	1.81e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—P4HB—prostate cancer	1.78e-06	1.8e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—MTHFR—prostate cancer	1.78e-06	1.8e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—RXRA—prostate cancer	1.76e-06	1.78e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMS—prostate cancer	1.76e-06	1.78e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARA—prostate cancer	1.74e-06	1.76e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—prostate cancer	1.74e-06	1.76e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GGT1—prostate cancer	1.73e-06	1.75e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.73e-06	1.75e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.72e-06	1.74e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOA2—prostate cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—LPL—prostate cancer	1.71e-06	1.73e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NCOA1—prostate cancer	1.71e-06	1.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—COMT—prostate cancer	1.7e-06	1.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—prostate cancer	1.69e-06	1.71e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.69e-06	1.71e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.68e-06	1.7e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—MTHFR—prostate cancer	1.68e-06	1.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ITPR1—prostate cancer	1.66e-06	1.68e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—prostate cancer	1.66e-06	1.68e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MED12—prostate cancer	1.66e-06	1.68e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.65e-06	1.67e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARA—prostate cancer	1.65e-06	1.67e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GNG5—prostate cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CAV1—prostate cancer	1.64e-06	1.66e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ERCC2—prostate cancer	1.64e-06	1.66e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—RXRA—prostate cancer	1.62e-06	1.64e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.6e-06	1.62e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NQO1—prostate cancer	1.58e-06	1.6e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMS—prostate cancer	1.57e-06	1.59e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—COMT—prostate cancer	1.56e-06	1.58e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TH—prostate cancer	1.56e-06	1.57e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.56e-06	1.57e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—prostate cancer	1.55e-06	1.57e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CAV1—prostate cancer	1.55e-06	1.57e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.55e-06	1.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.54e-06	1.56e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—MTHFR—prostate cancer	1.54e-06	1.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.53e-06	1.55e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.53e-06	1.55e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—LPL—prostate cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.52e-06	1.53e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.51e-06	1.53e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARA—prostate cancer	1.51e-06	1.53e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.5e-06	1.52e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.49e-06	1.51e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.48e-06	1.5e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.47e-06	1.49e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ACHE—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GGT1—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ERCC2—prostate cancer	1.46e-06	1.48e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.45e-06	1.47e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMS—prostate cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.43e-06	1.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.42e-06	1.44e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CAV1—prostate cancer	1.42e-06	1.44e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—INS—prostate cancer	1.41e-06	1.43e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.41e-06	1.43e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.41e-06	1.43e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.4e-06	1.42e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—LPL—prostate cancer	1.4e-06	1.42e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CREBBP—prostate cancer	1.38e-06	1.4e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—RXRA—prostate cancer	1.38e-06	1.39e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.37e-06	1.39e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—prostate cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARA—prostate cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.34e-06	1.36e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.34e-06	1.35e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—INS—prostate cancer	1.34e-06	1.35e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—COMT—prostate cancer	1.32e-06	1.34e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.32e-06	1.34e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.31e-06	1.33e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CREBBP—prostate cancer	1.31e-06	1.32e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.28e-06	1.29e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CAV1—prostate cancer	1.27e-06	1.28e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.24e-06	1.25e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARA—prostate cancer	1.24e-06	1.25e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NOS3—prostate cancer	1.24e-06	1.25e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.23e-06	1.25e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMS—prostate cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—INS—prostate cancer	1.22e-06	1.24e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NQO1—prostate cancer	1.22e-06	1.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.21e-06	1.22e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.21e-06	1.22e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TH—prostate cancer	1.2e-06	1.22e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CREBBP—prostate cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LPL—prostate cancer	1.19e-06	1.2e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NOS3—prostate cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CAV1—prostate cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.15e-06	1.17e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.14e-06	1.16e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—prostate cancer	1.13e-06	1.15e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GGT1—prostate cancer	1.13e-06	1.14e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.12e-06	1.13e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.1e-06	1.11e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—INS—prostate cancer	1.09e-06	1.1e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.08e-06	1.09e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NOS3—prostate cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—RXRA—prostate cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARA—prostate cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—COMT—prostate cancer	1.02e-06	1.03e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.02e-06	1.03e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—INS—prostate cancer	1.01e-06	1.02e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ITPR1—prostate cancer	1e-06	1.01e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—prostate cancer	9.91e-07	1e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—prostate cancer	9.89e-07	9.99e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CAV1—prostate cancer	9.88e-07	9.98e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CREBBP—prostate cancer	9.84e-07	9.95e-06	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—prostate cancer	9.82e-07	9.93e-06	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NOS3—prostate cancer	9.58e-07	9.69e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMS—prostate cancer	9.46e-07	9.56e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.43e-07	9.54e-06	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—EP300—prostate cancer	9.43e-07	9.53e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—prostate cancer	9.35e-07	9.45e-06	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—prostate cancer	9.34e-07	9.44e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—prostate cancer	9.33e-07	9.44e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LPL—prostate cancer	9.18e-07	9.28e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—prostate cancer	9e-07	9.09e-06	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—EP300—prostate cancer	8.91e-07	9e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1A1—prostate cancer	8.86e-07	8.96e-06	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—prostate cancer	8.85e-07	8.94e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NOS3—prostate cancer	8.81e-07	8.91e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ERCC2—prostate cancer	8.79e-07	8.89e-06	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—prostate cancer	8.77e-07	8.86e-06	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—prostate cancer	8.56e-07	8.66e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—INS—prostate cancer	8.51e-07	8.61e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CREBBP—prostate cancer	8.34e-07	8.43e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTHFR—prostate cancer	8.26e-07	8.35e-06	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—EP300—prostate cancer	8.17e-07	8.26e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—prostate cancer	8.14e-07	8.22e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARA—prostate cancer	8.11e-07	8.19e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—prostate cancer	8.06e-07	8.15e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—prostate cancer	7.91e-07	7.99e-06	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—prostate cancer	7.64e-07	7.73e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CAV1—prostate cancer	7.62e-07	7.7e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NOS3—prostate cancer	7.47e-07	7.55e-06	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—EP300—prostate cancer	7.29e-07	7.37e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—prostate cancer	7.03e-07	7.11e-06	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—prostate cancer	6.98e-07	7.05e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.94e-07	7.02e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—prostate cancer	6.89e-07	6.97e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—prostate cancer	6.83e-07	6.9e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—EP300—prostate cancer	6.7e-07	6.78e-06	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—prostate cancer	6.59e-07	6.66e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—INS—prostate cancer	6.57e-07	6.64e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CREBBP—prostate cancer	6.44e-07	6.51e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.1e-07	6.17e-06	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—prostate cancer	6.04e-07	6.11e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—prostate cancer	5.96e-07	6.02e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NOS3—prostate cancer	5.76e-07	5.83e-06	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—prostate cancer	5.7e-07	5.76e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—EP300—prostate cancer	5.68e-07	5.74e-06	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.39e-07	5.45e-06	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—prostate cancer	5.38e-07	5.44e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.32e-07	5.38e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—prostate cancer	5.27e-07	5.33e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.96e-07	5.01e-06	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—prostate cancer	4.94e-07	4.99e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—prostate cancer	4.6e-07	4.65e-06	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—prostate cancer	4.41e-07	4.45e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—EP300—prostate cancer	4.38e-07	4.43e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.2e-07	4.25e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—prostate cancer	4.05e-07	4.1e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—prostate cancer	3.43e-07	3.47e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.24e-07	3.28e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—prostate cancer	2.65e-07	2.68e-06	CbGpPWpGaD
